Nucleoside Analogs in ADAR Guide Strands Enable Editing at 5'-GA Sites

Area of Science:

• Biochemistry
• Molecular Biology
• RNA Biology

Background:

• Adenosine Deaminases Acting on RNA (ADARs) are enzymes that modify RNA by converting adenosine to inosine.
• ADARs are crucial for transcriptome regulation and have therapeutic potential for correcting mutations.
• Efficient RNA editing is hindered by ADARs' sequence preference, particularly at 5"-GA sites.

Purpose of the Study:

• To investigate modified oligonucleotides for enhancing ADAR editing efficiency at 5 -GA sites.
• To understand the structural basis for improved editing at 5 -GA sites using modified nucleosides.
• To develop metabolically stable guide RNAs for in vivo applications.

Main Methods:

• Synthesis and testing of modified guide oligonucleotides with purine or size-expanded nucleoside analogs.
• High-resolution crystal structure determination of ADAR:RNA substrate complexes.
• Assessment of metabolic stability of modified guide sequences in human cells.

Main Results:

• Modified adenosine and inosine analogs significantly enhance editing at 5 -GA sites.
• A size-expanded cytidine analog also improved editing efficiency compared to standard cytidine.
• Crystal structures revealed how inosine and expanded cytidine activate editing at these challenging sites.
• Optimized guide sequences with purine analogs showed improved editing and metabolic stability.

Conclusions:

• Specific nucleoside modifications in guide RNAs can overcome ADAR sequence preferences.
• This strategy enhances RNA editing at previously inefficient 5 -GA sites.
• The findings support the development of improved ADAR-based gene therapy and RNA editing tools.